Sorry, you need to enable JavaScript to visit this website.

DHR Health System announces plan underway to collect convalescent plasma that may be used to treat patients who are critically-ill from COVID-19

A plan is underway by DHR Health System to collect convalescent plasma – specifically antibody-rich blood products that are taken from blood donated from people who have recovered from the COVID-19 virus – that could shorten the length, or lessen the severity of the contagious and dangerous illness. Antibody, also called immunoglobulin, is a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing ...

PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news. Not yet a subscriber? Subscribe today!

Advance Publishing Company

217 W. Park Avenue
Pharr, TX 78577